This is not the most recent version of the article. View current version (5 JUN 2014)

Intervention Protocol

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients

  1. Luit Penninga1,2,*,
  2. Andre Wettergren2,
  3. Colin H Wilson3,
  4. An-Wen Chan4,
  5. Daniel A Steinbrüchel5,
  6. Christian Gluud6

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 11 OCT 2012

DOI: 10.1002/14651858.CD010253


How to Cite

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010253. DOI: 10.1002/14651858.CD010253.

Author Information

  1. 1

    Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark

  2. 2

    Rigshospitalet, Copenhagen University Hospital, Department of Surgery and Transplantation C2122, Copenhagen, Denmark

  3. 3

    The Freeman Hospital, Transplant Surgery, Newcastle-upon-Tyne, Tyne and Wear, UK

  4. 4

    University of Toronto, Women's College Research Institute, Toronto, ON, Canada

  5. 5

    Rigshospitalet, Copenhagen University Hospital, Department of Cardiothoracic Surgery, RT 2152, Copenhagen, Denmark

  6. 6

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Luit Penninga, LP@ctu.rh.dk. luitpenninga@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (05 JUN 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of T-cell specific antibody induction compared with placebo, no induction, or another type of antibody induction in liver transplant recipients.